Prescription Management (Topical & Systemic)

Prescription management is a core component of dermatological care, encompassing the selection, initiation, and ongoing optimization of medications for a wide range of skin conditions. An evidence-based approach is applied to ensure that each treatment plan is tailored to the individual patient, balancing therapeutic efficacy with safety and tolerability.

Topical Therapies

Topical therapies are the first line of treatment for many dermatological conditions. These medications are applied directly to the skin, allowing for targeted delivery to the affected area with minimal systemic absorption. The selection of a topical agent is guided by the diagnosis, disease severity, body site, and patient preferences.

Commonly prescribed topical medications include:

• Topical corticosteroids, ranging from mild to ultra-potent formulations, for inflammatory conditions such as eczema, psoriasis, and contact dermatitis
• Calcineurin inhibitors (tacrolimus, pimecrolimus) for sensitive areas and steroid-sparing maintenance therapy
• Topical retinoids (tretinoin, adapalene, tazarotene) for acne, photoaging, and keratinization disorders
• Topical antimicrobials and antifungals for infectious skin conditions

Proper instruction on application technique, frequency, and duration is provided to maximize therapeutic benefit and minimize potential side effects such as skin atrophy from prolonged corticosteroid use.

Systemic Medications

Systemic medications are prescribed when skin conditions are too widespread, severe, or refractory to be managed with topical treatments alone. These agents are taken orally or, in some cases, administered by injection, and act throughout the body to control disease activity.

Systemic agents commonly used in dermatology include:

• Methotrexate for psoriasis, eczema, and other inflammatory dermatoses
• Cyclosporine for severe atopic dermatitis and other immune-mediated conditions
• Acitretin for psoriasis and disorders of keratinization
• Isotretinoin for severe nodulocystic acne
• Systemic antibiotics for bacterial skin infections and inflammatory conditions such as rosacea

The decision to initiate systemic therapy involves a careful assessment of disease severity, the impact on quality of life, previous treatment responses, and the patient's overall health status.

Combination Approaches

Many dermatological conditions benefit from a combination of topical and systemic therapies. Combining treatments can enhance overall efficacy, allow for lower doses of individual agents, and reduce the risk of side effects. For example, a patient with moderate to severe psoriasis may receive a systemic agent for widespread disease control alongside topical corticosteroids for localized flares.

Treatment plans are designed to be dynamic, with medications adjusted or rotated as the condition evolves. Step-up and step-down approaches are commonly employed, where treatment intensity is escalated during flares and reduced during periods of remission.

Monitoring and Adjustment

Regular follow-up is essential for patients receiving prescription dermatological therapies, particularly systemic agents. Follow-up appointments allow for the assessment of treatment response, identification of side effects, and adjustment of the management plan as needed.

Laboratory monitoring is required for many systemic medications. Methotrexate necessitates regular complete blood counts and liver function tests. Cyclosporine requires monitoring of renal function and blood pressure. Isotretinoin treatment includes periodic lipid panels and liver function assessments. Adherence to monitoring schedules is critical for the safe use of these agents.

Medication Safety

Medication safety is a priority in dermatological prescription management. Potential drug interactions, contraindications, and patient-specific risk factors are carefully evaluated before initiating any medication. Particular attention is given to teratogenic medications, such as isotretinoin, acitretin, and methotrexate, which require strict pregnancy prevention measures and counselling for patients of reproductive potential.

Patients are educated about their medications, including proper use, expected timelines for improvement, signs of potential adverse effects, and the importance of adherence. Open communication between the patient and the dermatologist is encouraged to ensure that any concerns are addressed promptly.

At the Centre for Medical and Surgical Dermatology, Dr. Maksym Breslavets provides comprehensive prescription management for a full spectrum of dermatological conditions. Each treatment plan is developed using current evidence-based guidelines, with regular monitoring and follow-up to ensure safe, effective, and patient-centred care.